A federal appeals panel upheld a lower court’s ruling that millions of dollars’ worth of dietary supplements seized by the Food and Drug Administration from embattled Hi-Tech Pharmaceuticals was properly subject to forfeiture under federal law.

But the 2-1 opinion sets up a further challenge from the Norcross-based supplement company and its CEO, Jared Wheat, who has been battling the FDA for years and faces separate criminal charges related to his marketing of other products.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]